824 results found
If you have received an MRFF grant and circumstances have changed – for example, there has been a delay in your research activity – you can apply to vary your grant.
Grant outcomes for the 2026 NHMRC grant application round will be provided incrementally throughout the year. The outcome datasets may include a small number of schemes for which applications closed in the previous year.
The 32nd biannual report.
The Report of the Independent Review of the Prohibition of Human Cloning for Reproduction Act 2002 and the research involving human embryos Act 2002 offers a review of legislation regarding the use of human clones for reproduction and the use of human embryos in research.
Information for Administering Institutions reporting on compliance.
Review of the use of microwave therapy for the treatment of patients with cancer is the final report on the therapeutic effectiveness of microwave (UHF radiowave) cancer therapy as practised by Dr John Holt in Western Australia.
The 43rd biannual report
At NHMRC, we aim to create a workplace which supports all staff, regardless of their gender, age, cultural or religious background, sexual orientation or personal attributes. We want NHMRC to be a flexible and fair work environment, in which staff can flourish and where differences between employees are respected and viewed as an organisational asset.
The NHMRC Research Integrity and Misconduct Policy clarifies the role and responsibilities of NHMRC Administering Institutions about notifying NHMRC of research integrity matters and describes how NHMRC responds to such matters.
The 31st biannual report.
The 42nd biannual report
The 34th biannual report
Ensuring the ethical, humane and responsible use of animals in health and medical research forms part of the sector’s social licence to operate in Australia.
The 27th biannual report.
The Australian Government's Boosting Dementia Research Initiative invested $200 million over 5 years from 2014 to 2019 to accelerate research, enhance collaboration and promote advances in dementia research and treatment. The Boosting Dementia Research Initiative (BDRI) consisted of two main elements:
Licence holders are responsible for ensuring that their organisations comply with licence conditions. Each person who is identified in the licence conditions as an authorised person must be fully informed about the licence and its conditions and the requirements of the legislation and any corresponding state or territory law.